SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Pump Mind Virus is a Pure Meme with a long term vision. We are building for the future while making no promises about the present. The project aims to bring the spirit of community memes back to the Solana ecosystem. We do that with engaging content and memes. Culture through community. Viral spread by word of mouth.  And most importantly, by not using the fake hype machine that has come to dominate the meme coin landscape.

PumpMindVirus

PumpMindVirus ($PMV) is trending due to its strong community and meme-driven culture, with community members actively spreading awareness of the "infection". The coin, originating from $PUMP on the Solana chain, emphasizes fun and energy, attracting attention from those seeking engaging meme-based investments. The community is celebrating its organic growth and the "virus" spreading across multiple platforms, expressing confidence for the future.

Netflix, Inc. engages in providing entertainment services. It also offers activities for leisure time, entertainment video, video gaming, and other sources of entertainment. It operates through the United States and International geographic segments. The company was founded by Marc Randolph and Wilmot Reed Hastings on August 29, 1997 and is headquartered in Los Gatos, CA.

Netflix Inc.

Netflix Inc

Recent news of Netflix potentially acquiring Warner Bros. is driving significant conversation around $NFLX. The community is discussing the potential impact of this deal, including concerns about market share and regulatory hurdles, while some see it as a strategic move for content dominance and long-term growth. Community members are actively speculating on the deal's likelihood and its potential effects on the streaming landscape.

Treasure Global, Inc. engages in the provision of payment solutions. The firm created an online-to-offline (O2O) e-commerce platform business model offering consumers and merchants instant rebates and affiliate cashback programs. It operates through the ZCITY Platform and Customized Software Development Service segments. The company was founded by Kok Pin Tan on March 20, 2020 and is headquartered in New York, NY.

Treasure Global Inc

TREASURE GLOBAL INC

TGL is trending due to a recent reverse stock split and community excitement around potential short squeeze opportunities, drawing comparisons to SMX's recent surge. Traders are closely watching for continued momentum and potential catalysts related to the company's growth initiatives. Bullish sentiment is high, with some expecting a significant run-up next week.

Immix Biopharma, Inc. operates as a biopharmaceutical company that engages in the development of therapies for cancer and inflammatory diseases. The company was founded by Ilya Rachman, Sean Senn, and Vladimir Torchilin in 2012 and is headquartered in Los Angeles, CA.

Immix Biopharma Inc

Immix Biopharma is trending due to positive community sentiment surrounding their ASH oral data and a subsequent upsized $100M offering, interpreted as a strong institutional buy signal.  The community is focused on the implications of the upsized offering after the data release, suggesting confidence in the company's prospects. Discussions revolve around the potential for an accelerated BLA submission and future buyout opportunities.

Top Wealth Group Holding Ltd. operates as a holding company, which provides caviar and caviar-based gourmet products. It focuses on supplying sturgeon caviar to customers under its own brand, Imperial Cristal Caviar. The company was founded by Kim Kwan Kings Wong on February 1, 2023 and is headquartered in Hong Kong.

Top Wealth Group Holding Ltd. - Ordinary Shares - Class A

Top Wealth Group Holding Ltd.

TWG is trending as traders discuss its potential for a significant squeeze, drawing comparisons to recent runners like $SMX and $TGL. Community members are focused on the stock's low float and a reported FY25 profit outlook as potential catalysts. Some traders caution about risks associated with Hong Kong-based companies and potential dilutions.

Structure Therapeutics, Inc. is a clinical stage global biopharmaceutical company, which engages in developing novel oral therapeutics to treat a wide range of chronic diseases with unmet medical needs. Its pipeline includes Aleniglipron GSBR-1290, ACCG-2671, GIPR, GCGR, ANPA-0073, and LTSE-2578. The company was founded by Raymond C. Stevens in 2016 and is headquartered in South San Francisco, CA.

Structure Therapeutics Inc - ADR

Structure Therapeutics ($GPCR) is trending as investors discuss its upcoming P2 data release and potential competition with other GLP-1 drugs. The community is focused on evaluating the data quality and management's strategic moves to shape the narrative. Some traders are also noting unusual options activity, while analysts weigh in on potential buyouts and price targets.

ProShares Trust - ProShares UltraShort Bloomberg Natural Gas -2x Shares

ProShares UltraShort Bloomberg Natural Gas

KOLD is trending as traders discuss the impact of weather patterns and natural gas storage levels on its price, with some anticipating a potential reversal while others remain cautious due to high production. Community members are actively trading around volatility, with differing opinions on whether recent price movements are sustainable amid winter demand and contract rollovers. Discussions also involve technical analysis and potential chart patterns.

MetaVia, Inc. is a clinical-stage biotechnology company, which engages in developing and commercializing multi-modal disease-modifying therapies. Its pipeline includes ANA001, a proprietary oral niclosamide formulation, Gemcabene, which is assessed as an acute indication for COVID-19, NB-01, a treatment for painful diabetic neuropathy, and NB-02, which has the potential to treat the symptoms of cognitive impairment and modify the progression of neurodegenerative diseases. The company was founded on October 30, 2014 and is headquartered in Cambridge, MA.

MetaVia Inc.

MTVA is trending due to community discussion around its low float and potential for significant price movement, with traders actively monitoring overnight action and anticipating a continued run. Some investors are optimistic about potential catalysts and the company's pipeline, while others express caution regarding dilution and the company's financials, contributing to the stock's volatile trading pattern.

GameStop Corp. engages in offering games and entertainment products through its ecommerce properties and stores. The firm’s stores and ecommerce sites operate primarily under the names GameStop, EB Games, and Micromania. It operates through the following geographical segments: United States, Canada, Australia, and Europe. The company was founded by Daniel A. DeMatteo in 1996 and is headquartered in Grapevine, TX.

Gamestop Corporation - Ordinary Shares - Class A

GameStop Corp

GameStop is trending amid discussions of potential catalysts like upcoming earnings and speculation around key figures like Roaring Kitty and Michael Burry. The community is actively dissecting trading patterns, potential gamma ramps, and the impact of large buy orders, while also eyeing the performance of GME warrants. Some traders express frustration with persistent price suppression despite positive fundamentals and potential short squeezes.

Dyne Therapeutics, Inc. engages in developing innovative life-transforming therapies for genetically driven muscle diseases. It develops a broad portfolio of therapeutics for muscle diseases, including lead programs in myotonic dystrophy type 1, Duchenne muscular dystrophy, and facioscapulohumeral muscular dystroph. The company was founded by Jason P. Rhodes and Romesh R. Subramanian on December 1, 2017 and is headquartered in Waltham, MA.

Dyne Therapeutics Inc

Dyne Therapeutics is trending due to upcoming topline clinical results from their DELIVER trial of DYNE-251 in Duchenne Muscular Dystrophy, with a webcast planned to review the data. The community is discussing the potential impact of these results, especially in relation to existing treatments like Sarepta's. Traders are also eyeing the stock, and providing potential ROI.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Geode Capital Management LLC Raises Stock Holdings in Rezolute, Inc. $RZLT

Geode Capital Management LLC increased its stake in Rezolute, Inc. (NASDAQ:RZLT - Free Report) by 201.7% during the 2nd quarter, according to the company in its most recent disclosure with the...

Traders Buy Large Volume of Put Options on Rezolute (NASDAQ:RZLT)

Rezolute, Inc. (NASDAQ:RZLT - Get Free Report) was the recipient of some unusual options trading on Thursday. Stock traders purchased 2,877 put options on the stock. This represents an increase of...

Stonepine Capital Management LLC Takes Position in Rezolute, Inc. $RZLT

Stonepine Capital Management LLC bought a new stake in shares of Rezolute, Inc. (NASDAQ:RZLT - Free Report) during the second quarter, according to the company in its most recent filing with the...

How Much Upside is Left in Rezolute (RZLT)? Wall Street Analysts Think 56.58%

The consensus price target hints at a 56.6% upside potential for Rezolute (RZLT). While empirical research shows that this sought-after metric is hardly effective, an upward trend in earnings estimate revisions could mean that the stock will witness an upside in the near term.

Cantor Fitzgerald Expects Stronger Earnings for Rezolute

Rezolute, Inc. (NASDAQ:RZLT - Free Report) - Investment analysts at Cantor Fitzgerald upped their FY2026 earnings per share estimates for shares of Rezolute in a research note issued on Monday...

All You Need to Know About Rezolute (RZLT) Rating Upgrade to Buy

Rezolute (RZLT) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).

Can Rezolute (RZLT) Climb 49.4% to Reach the Level Wall Street Analysts Expect?

The consensus price target hints at a 49.4% upside potential for Rezolute (RZLT). While empirical research shows that this sought-after metric is hardly effective, an upward trend in earnings estimate revisions could mean that the stock will witness an upside in the near term.

Rezolute (NASDAQ:RZLT) Shares Down 7.9% - Here's Why

Rezolute (NASDAQ:RZLT) Shares Down 7.9% - Time to Sell...

HC Wainwright Has Weak Estimate for Rezolute FY2030 Earnings

Rezolute, Inc. (NASDAQ:RZLT - Free Report) - Analysts at HC Wainwright lowered their FY2030 EPS estimates for Rezolute in a note issued to investors on Friday, November 7th. HC Wainwright analyst D...

Rezolute (NASDAQ:RZLT) Announces Quarterly Earnings Results, Beats Expectations By $0.09 EPS

Rezolute (NASDAQ:RZLT - Get Free Report) issued its quarterly earnings results on Thursday. The company reported ($0.18) earnings per share for the quarter, topping the consensus estimate of ($0.27...

Rezolute, Inc. operates as a biopharmaceutical company, which engages in the development of drug therapies for patients with metabolic and orphan diseases. The firm's antibody therapy, ersodetug, is designed to treat all forms of hyperinsulinism. The company was founded by Nevan Charles Elam, Ho Young Huh, and Sankaram Mantripragada in March 2010 and is headquartered in Redwood City, CA.

Rezolute Inc

$SOFI

$RDDT

$CVNA

$MSTR

Which stock do you think gets added to the S&amp;P 500 in today’s rebalance?

Stocktwits

Which stock do you think gets added to the S&P 500 in today’s rebalance?

Current Price	$10.42
Prev Close	$9.70
Open	$9.74
Dividend Yield	0.00%
50-Day Moving Average	$9.39
Beta	1.00
Avg. Volume	1.49M
PE Ratio	-11.22

52-Week High	$11.46
52-Week Low	$2.22
Market Capitalization	$966.22M
EPS (Annual)	-$0.9791
Price to Book	6.45
Revenue Per Employee	$0.00
Enterprise Value/EBITDA	N/A

RZLT
Rezolute Inc

Feed

News

Sentiment

Earnings

Fundamentals

Info

Latest RZLT News

RZLTRezolute Inc